New Gene-Editing Tool Promises Better Medical Treatments
新型基因編輯工具預示著更佳的醫療方案
The landscape of medicine is undergoing a revolution as we enter the second wave of gene editing.
隨著我們進入基因編輯的第二波浪潮，醫學領域正經歷一場革命。
Scientists are now prioritizing safety, scalability, and the ability to perform treatments directly inside the human body, known as in vivo delivery.
科學家們現在優先考慮安全性、可擴展性以及直接在人體內進行治療的能力，即所謂的體內傳遞。
A major breakthrough is the development of the miniaturized enzyme Al3Cas12f, which is small enough to be transported into human cells to treat conditions like cancer and ALS.
一項重大的突破是微型酶 Al3Cas12f 的開發，它小到足以被運送到人類細胞中，以治療癌症和肌萎縮性側索硬化症等疾病。
By acting like a pencil and eraser instead of cutting DNA strands, this method minimizes the risk of harmful off-target mutations.
透過像鉛筆和橡皮擦一樣運作，而不是切斷 DNA 鏈，這種方法最大限度地減少了有害的脫靶突變風險。
With the help of AI, researchers are optimizing these tools to ensure that theoretical breakthroughs evolve into reliable, life-saving therapies for patients worldwide.
在人工智慧的幫助下，研究人員正在優化這些工具，以確保理論上的突破能轉化為全球患者可靠且能挽救生命的療法。
